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ABSTRACT
Background: Instrumental Activities of Daily Living
(IADL) questionnaires can be helpful in diagnosing
dementia and are often used for clinical follow-up and
treatment evaluation in dementia patients. Despite the
large number of questionnaires, their quality has received
little attention.
Objective: To systematically review the measurement
properties of all available structured informant-based
(I)ADL questionnaires, developed or validated for use in
demented patients.
Methods: A systematic literature search was conducted
in MEDLINE, PsycINFO and EMBASE for psychometric
articles on (I)ADL questionnaires. In addition, reference
lists of all retrieved articles were screened. Standardised
criteria were used to assess the quality of the
measurement properties. When possible, investigators
were contacted to obtain missing information. Two
authors independently extracted studies and performed
the quality assessment of the questionnaires.
Findings: Thirty-two articles were selected, covering 12
(I)ADL questionnaires. Information on 52.3% of the quality
aspects was not available, 32.4% of the ratings were
indeterminate, 8.1% were positive, and 7.2% were
negative. Out of eight measurement properties, two
scales (the DAD and the Bristol ADL) received two
positive ratings and were classified as of moderate
quality. Five scales (ADL-PI, ADL-IS, B-ADL, CSADL and
Lawton IADL) received one positive rating.
Interpretation: The findings indicate that improvements
in and more data on psychometric properties of (I)ADL
questionnaires for dementia patients are necessary in
order to justify their use.
Functional decline is an essential feature of all
dementias and is therefore embedded in the
diagnostic criteria for dementia.1 This decline is
commonly assessed using ‘‘functional ability’’ or
‘‘activities of daily living’’ measurement instru-
ments. Activities of daily living can be divided into
Basic Activities of Daily Living (BADL) and
Instrumental Activities of Daily Living (IADL).
BADL are self-maintenance skills such as bathing,
dressing and toileting. IADL involve more complex
activities, such as preparing a meal, handling
finances and shopping.2 These instrumental activ-
ities generally require a greater complexity of
neuropsychological organisation and are in conse-
quence more likely to be vulnerable to the early
effects of cognitive decline.2–6 Measuring IADL can
therefore be helpful in diagnosing early dementia.7–10
Since IADL also gives an indication of patient
dependency, it is frequently used for clinical
follow-up and to evaluate treatments.8 9 11
Methods to assess IADL comprise self-reported
questionnaires, performance-based assessment and
informant-based questionnaires. Self-reported
questionnaires are difficult to assess in dementia
patients, since disease insight is frequently
impaired.12–15 Observation or direct assessment
has the advantage of directly obtaining informa-
tion without relying on self- or informant report.
Nonetheless, a major drawback of this method is
the time-consuming aspect of these instruments,
with assessment times up to 1.5 h.8 16 Hence, the
most common method is the use of informant-
based questionnaires.
A large number of these (I)ADL informant-based
questionnaires are available, and their number is
still growing.8 17 Despite the widespread use of
these questionnaires, little attention has been paid
to their quality. For example, in the light of an
early diagnosis of dementia, it still remains unclear
which of the existing IADL questionnaires might
identify people at risk for dementia.7
A critical review of IADL questionnaires is
therefore timely and needed in view of the
expected increase in clinical trials in early
Alzheimer disease (AD). Here, we provide an
overview of all available structured informant-
based IADL questionnaires, developed or validated
for the use in AD. Additionally, we set out to
evaluate the psychometric properties of these
questionnaires. Our final aim was to identify
questionnaires useful in the identification of early
dementia, particularly in young patients.
METHODS
Data sources
Computer-based literature searches were per-
formed in the PubMed (1950–2007), PsycINFO
(1887–2007) and Embase (1966–2007) databases,
concluding in November 2007. These databases
were searched with the search terms Activities of
daily living (MeSH), dement*, Alzheimer*, iadl,
instrumental adl, instrumental activities of daily
living, extended ADL, complex ADL, advanced
ADL, functional ability, everyday functioning and
activities of daily living. An additional search was
conducted with the terms ADL (MeSH) and
dementia (MeSH), to ensure no questionnaires
were missed. No limits were set in languages. Case
reports and clinical trials were excluded. Two
authors (EdL-dK and SS) independently screened
abstracts and titles to identify those articles
Review
J Neurol Neurosurg Psychiatry 2009;80:7–12. doi:10.1136/jnnp.2008.155838 7
 group.bmj.com on August 16, 2011 - Published by jnnp.bmj.comDownloaded from 
relevant to the research question. In addition to the compu-
terised databases, a book with an overview of assessment scales
in old age psychiatry was hand-searched.18 Reference lists of all
articles related to the research question were screened, and
potentially relevant articles were subsequently retrieved and
assessed.
Data extraction and data synthesis
Questionnaires aimed at measuring (I)ADL, complex ADL,
advanced ADL, functional ability, functional disability or
everyday functioning were selected. When the primary mea-
surement aim was otherwise, for example quality of life or
general deterioration, the questionnaire was excluded. The
questionnaire had to be disease-specific, that is developed or
validated for use in dementia patients. In addition, the
questionnaire had to be structured and informant-based. In
consequence, self-report or clinical judgement scales without
operationally defined anchor points were excluded.
Furthermore, the questionnaire had to be developed or validated
for use in Western society (Europe or Northern America).
A study was selected when its primary objective was the
development or the clinimetric evaluation of an (I)ADL
questionnaire. We aimed to identify the original validation
article and all subsequent psychometric articles. Studies addres-
sing other objectives, such as treatment evaluation, were
excluded to avoid circular reasoning.
All questionnaires meeting the inclusion and exclusion
criteria outlined above were incorporated in the review. They
were reviewed on relevant psychometric characteristics accord-
ing to the ‘‘quality criteria for measurement properties of health
status questionnaires’’ developed by Terwee et al.19 Authors
were contacted if further information, such as additional
unpublished data, was required.
Quality assessment of the questionnaires
The quality of the questionnaires was evaluated on the
following eight measurement properties: (1) content validity,
(2) internal consistency, (3) criterion validity, (4) construct
validity, (5) reproducibility, (6) responsiveness, (7) floor- and
ceiling effects and (8) interpretability. Each aspect was rated as
positive, negative or indeterminate, depending on the design,
methods and outcomes of the studies. The quality and rating
criteria are outlined in the appendix (I).
In general, a positive rating was given when the study was
adequately designed, executed and analysed, had adequate
sample sizes and had satisfying results. An indeterminate rating
was given when there was an inadequate (description of) design
and execution, inadequate methods or analyses, the sample size
was too small, or there were methodological shortcomings. A
negative rating was given when unsatisfactory results were
found despite adequate design, execution, methods, analyses
and sample size. When information about the relating criteria
was lacking, a ‘‘no information available’’ rating was given.
Two authors (ESMdL-dK and SAMS) independently rated the
questionnaires, and discrepancies were resolved by consensus.
Where consensus could not be reached, a third reviewer was
consulted.
Content validity
The content validity refers to the way in which items of the
questionnaire cover the domain(s) under investigation.20 In
order to be able to judge the content validity of a questionnaire,
authors should provide information regarding the measurement
aim of the questionnaire, the target population, the concepts
the questionnaire intends to measure, the process of item
selection and the interpretability of the items.19 The items of the
questionnaire should contain relevant items, and to ensure its
relevance, the target population should have been involved in
the process of item selection to obtain a positive rating on this
property.
Internal consistency
Internal consistency concerns the extent to which items in a
(sub)scale are correlated, and are as such measuring the same
concept.19 20 In order to evaluate the internal consistency,
authors should have performed a factor analysis to check for
subscales in the questionnaire. When subscales are found, the
internal consistency should have been tested separately for
these subscales. Internal consistency can be determined by
calculating the Cronbach alpha.21 A positive rating for this
property was obtained when the Cronbach alpha was between
0.70 and 0.95.
Criterion validity
Criterion validity refers to the extent to which scores on a scale
relate to another measure of the construct under study, ideally a
‘‘gold standard.’’20 A positive rating is given if the correlation
with the gold standard is at least 0.70.
Construct validity
When no absolute ‘‘gold standard’’ is available, the validity
must be investigated by means of indirect evidence, such as
establishing the construct validity.21 A construct is some
postulated attribute of people, assumed to be reflected in test
performance.21 To investigate construct validity, the scores on
the questionnaire under study are correlated with scores on
other measurement instruments which are known to be related
(or not) to the construct under study. Authors should provide
hypotheses about the relation between the construct under
study and the other constructs in advance, and at least 75% of
the results should be in correspondence with the hypotheses to
receive a positive rating.19 20
Reproducibility
Reproducibility concerns the degree to which repeated measure-
ments in stable patients provide the same results.22 The concept
of reproducibility embraces two aspects, namely agreement and
reliability. Reliability addresses whether patients can be
distinguished from each other, despite measurement error.
This can be determined by calculating a reliability parameter,
generally an Intraclass Correlation Coefficient (ICC).23 The ICC
for agreement, which reflects both systematic and random
differences in test scores, is preferred. A positive rating is given
when the ICC is at least 0.70.19 The second aspect, agreement,
reflects the extent to which repeated measurements give the
same results. This can be expressed as the standard error of
measurement (SEM) or with the limits of agreement of Bland
and Altman.19 22 In case of high agreement, the measurement
error is small. The SEM can be converted into the smallest
detectable change (SDC), which is the smallest within-person
change, above measurement error. A positive rating is given
when the SDC or the limits of agreement are smaller than the
minimal important change (MIC).19 The MIC is the smallest
difference in score in the domain of interest which patients
perceive as beneficial and would mandate, in the absence of
troublesome side effects and excessive costs.19
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Responsiveness
Responsiveness is the ability of a questionnaire to detect a
meaningful or clinically important change over time in a clinical
state.20 24 To detect such a change, the questionnaire should be
able to distinguish clinically important change from measure-
ment error. Responsiveness is determined by calculating
Guyatt’s responsiveness ratio (RR) or the area under the
receiver operating characteristics (ROC) curve (AUC). The
latter is a measure of the ability to distinguish patients who
have and have not changed, according to an external criterion. A
positive rating was given when the RR was at least 1.96 or the
AUC was at least 0.70.19
Floor- and ceiling effects
Floor- or ceiling effects are present if more than 15% of the
patients obtain the lowest or highest possible score. In
consequence, patients in these upper or lower ends cannot be
distinguished from each other, and change cannot be measured.
A positive rating was given when these effects were absent.19
Interpretability
Lastly, the interpretability of the questionnaire is rated. This is
the extent to which one can assign qualitative meaning to
quantitative scores. One can interpret scores on a questionnaire
when information is present concerning what score or change in
score is clinically meaningful. Authors received a positive rating
when they provided scores of a reference population and
relevant subgroups of patients, and when a MIC was defined to
enable interpretation of change scores over time.19
RESULTS
The initial Medline search produced 2104 possible sources
referring to (I)ADL in combination with dementia. All abstracts
and titles were screened using the inclusion/exclusion criteria.
Twenty-three articles relevant to the research question were
identified, covering 13 questionnaires. The additional searches
in Psycinfo and Embase disclosed one other relevant article.
Cross-referencing led to the identification of another six articles.
Resources were unavailable to translate two possibly relevant
articles (Spanish and French, concerning the Lawton & Brody
IADL questionnaire). One questionnaire (the Daily Activities
Questionnaire) was excluded because it was developed with
item response techniques (instead of classical test theory), and
the quality criteria were not suitable for these techniques.25 26
For further investigation, 28 articles covering 12 questionnaires
were selected. Table 1 provides the full names and abbreviations
of the questionnaires.
Description of questionnaires
Table 2 presents an overview of the included questionnaires.
The ADCS-ADL, ADCS-ADL-sev, ADL-IS, ADLQ, B-ADL,
Blessed DS, Bristol ADL, CSADL, DAD and IDDD were
disease-specific scales for dementia patients.27–35 The ADLQ, B-
ADL, DAD and IDDD were aimed at community-dwelling
dementia patients, in the early stages of the disease. The ADCS-
ADL-sev was aimed at patients in later stages of dementia. The
ADL-PI was aimed at healthy older people in prevention trials
for AD.36 The Lawton IADL was a generic scale, developed for
community-resident older people.2 This questionnaire did not
meet the inclusion criteria, but was included by exception,
because it is currently the most widely applied IADL ques-
tionnaire for dementia patients.
Most questionnaires combined Instrumental ADL with Basic
ADL, behaviour, cognition or social functioning. The Lawton
IADL and the ADL-PI were the only scales designed to measure
exclusively IADL.2
The measurement aims of the questionnaires were to assess
ADL (ADCS-ADL-sev, Blessed DS, CSADL, DAD, IDDD,
Lawton IADL), to detect changes in ADL (ADL-PI, ADL-IS,
ADLQ, B-ADL) or both (ADCS-ADL, Bristol ADL). No
questionnaires were aimed at the early identification of
dementia in younger patients.
Content validity
In the development of most questionnaires, suggestions from
experts, investigators or the target population were incorpo-
rated. In some validation articles, no information about how the
generation and selection of the items took place was found,
such as in the Blessed DS, IDDD and the Lawton IADL articles.
For the ADLQ, no information about the target population
involvement was provided. Target population was involved in
the item selection of the Bristol ADL, ADL-IS, DAD and
CSADL. For all these questionnaires except the Bristol ADL,
there was also involvement of experts or investigators. No
target population was involved in the selection of items for the
B-ADL, item selection was performed by experts only.
Internal consistency
A Cronbach alpha was reported for the B-ADL, CSADL, DAD,
IDDD and Lawton IADL, ranging from 0.78 to 0.98. The only
studies in which factor analysis was performed prior to the
computation of the Cronbach alpha were studies of the Lawton
IADL and the B-ADL scale. For the B-ADL, the Cronbach alpha
was 0.98; for the Lawton IADL, two subscales were found, with
a Cronbach alpha of 0.91 and 0.78.
Criterion validity
Since there is no apparent ‘‘gold standard’’ available for ADL,
most studies did not provide information about criterion
validity. For the Blessed DS, however, the authors suggested
the senile plaque count in the brains of (diseased) patients as a
gold standard. The correlation with this standard for demented
patients was 0.40.
Construct validity
In most studies, other instruments in addition to the (I)ADL
questionnaire were administered, most frequently the MMSE.
For the ADLQ, hypotheses were presented relating to an
instrument measuring both ADL and behaviour. It was
expected that the correlation with ADLQ would be higher for
the ADL section than for the behaviour section. These
hypotheses were confirmed, with a correlation of 0.71 with
the ADL section and a correlation of 0.46 for the behaviour
section. For the Bristol ADL, hypotheses were also formed in
advance, which was explained in a personal communication by
Dr Romola S. Bucks (email, 14 May 2008). Hypotheses relating
to the magnitude and direction of expected relationships with
other instruments were not presented for any other question-
naires.
Reproducibility
Agreement
Information about agreement was only presented for the
Blessed DS. The limits of agreement were presented, but an
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MIC was not defined. Information regarding agreement was not
present for any of the other questionnaires.
Reliability
Reliability was investigated for nine questionnaires. Kappas were
computed for the ADLQ and Bristol ADL. Spearman rank-order
correlations were presented for the CSADL and B-ADL (personal
communication with Dr Hartmut Lehfeld, email, 8 April 2008).
Pearson correlations were presented for the ADL-PI. ICCs were
computed for the Blessed DS, DAD, DAQ, IDDD and Lawton
IADL, with values ranging from 0.30 to 0.94. The sample sizes for
the Lawton IADL were too small (,50 patients). For the DAD
and the Blessed DS, an ICC was obtained with an adequate
sample size (ICC = 0.95 and ICC = 0.30).
Responsiveness
Change over time was addressed in studies of the DAD, ADLQ,
ADL-PI, Lawton IADL, Bristol ADL and ADCS-ADL-sev. These
studies presented change scores over time only. Several studies
also compared change scores with scores on other related
measurement instruments. No MIC was defined for any of the
questionnaires.
Floor or ceiling effect
Floor or ceiling effects were reported for the CSADL (78%
obtained the lowest score) and the Lawton IADL (approxi-
mately 20% obtained the highest score). No floor or ceiling
effects were present for the B-ADL, as was explained in a
personal communication with Dr Hartmut Lehfeld (email, 8
April 2008). No or unclear information about possible floor or
ceiling effects was provided for the remaining questionnaires.
Interpretability
For eight questionnaires, information on different relevant
subgroups was available. These subgroups included groups of
different dementia severity, healthy older people, physically
impaired, MCI, depression or different age groups. The mean
and SD scores were presented in most articles.
Overall quality
Table 3 shows the overall quality assessment of the 12 (I)ADL
questionnaires, summarising each property as good (+), doubt-
ful (?), poor (2) or no information found (NA) according to the
criteria of Terwee et al.19 Information on 52.3% of the quality
aspects was not available, 8.1% of the ratings were positive,
Table 1 Abbreviations and full names of the identified questionnaires
Abbreviations Full names
1 ADCS-ADL Alzheimer Disease Cooperative Study Activities of Daily Living Inventory
2 ADCS-ADL-sev Alzheimer Disease Cooperative Study Activities of Daily Living Severe
3 ADL-PI Activities of Daily living Prevention Instrument
4 ADL-IS The Alzheimer Disease Activities of Daily Living International Scale
5 ADLQ Activities of Daily Living Questionnaire
6 B-ADL Bayer Activities of Daily Living Scale
7 Blessed DS Blessed Dementia Rating scale
8 Bristol ADL Bristol Activities of Daily Living Scale
9 CSADL Cleveland Scale for Activities of Daily Living
10 DAD Disability Assessment for Dementia
11 IDDD Interview for Deterioration in Daily Living Activities in Dementia
12 Lawton IADL Lawton & Brody Instrumental Activities of Daily Living Scale
Table 2 Descriptions of the questionnaires
Name Function measured Goal Assessment No of items
1 ADCS-ADL37 BADL and IADL To evaluate ADL abilities over time and detect changes
in patients with AD
Interview-based questionnaire 23
2 ADCS-ADL-sev27 BADL and IADL To assess ADL in moderate to severe Alzheimer
disease
Interview-based questionnaire 19
3 ADL-PI36 IADL and mobility To rate ADL in prevention of dementia trials Questionnaire, two versions: one
for patient, one for informant
20
4 ADL-IS28 ADL And ADL scale for pharmacological trials in AD Questionnaire 40
5 ADLQ4 29 BADL and IADL To track progression of functional decline over time in
dementia
Questionnaire 28
6 B-ADL30 38–40 BADL, IADL and
cognition
To measure changes in activities of daily living in the
early stages of dementia
Questionnaire 25
7 Blessed DS31 41 BADL, IADL and
behaviour
To describe in quantitative terms the degree of
intellectual and personality deterioration shown by a
dementia patient
Interview-based questionnaire 22
8 Bristol ADL32 42 BADL and IADL To provide a baseline assessment of ability of
demented subjects and to be sensitive of change
Questionnaire 20
9 CSADL33 43 44 BADL and IADL To characterise the functional difficulties of AD
patients as they progress from the mild to the more
severe stages of dementia
Interview-based questionnaire 47
10 DAD34 45 46 BADL, IADL and leisure
activities
To evaluate functional disability in community-dwelling
persons with Alzheimer disease through the use of a
proxy-respondent
Interview-based questionnaire 40
11 IDDD35 47 48 BADL and IADL To assess activities of daily living in dementia Interview-based questionnaire 33
12 Lawton IADL2 49–52 IADL To assess the functional ability of older people Interview-based questionnaire 8
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32.4% of the ratings were indeterminate, and 7.2% were
negative. The ADL-PI, ADL-IS, B-ADL, CSADL and Lawton
IADL received one positive rating, and the DAD and Bristol ADL
received two positive ratings.
DISCUSSION
We identified 12 questionnaires for the evaluation of (I)ADL in
dementia. None of these questionnaires provided information
for all measurement properties. Of the ratings, 8.1% were
positive, 7.2% were negative, and 32.4% were indeterminate,
often due to inadequate data analyses or sample sizes. Overall,
the DAD and the Bristol ADL received the best ratings for their
clinimetric properties. Although several questionnaires were
aimed at early dementia, no diagnostic questionnaire specific for
use in young patients was found.
To our knowledge, no previous study has systematically
addressed the psychometric properties of IADL questionnaires
for dementia patients using well-defined criteria. Previous
reviews described only the content of the scales or a limited
number of psychometric properties, without evaluating those
using clear criteria.8 53–56
In our study, the DAD and the Bristol ADL received the best
ratings, but when considering all eight quality aspects, these
questionnaires are only of moderate quality. The rating of the
questionnaires was complicated by the lack of psychometric
information. When possible, authors were contacted to obtain
missing information. Several authors provided additional informa-
tion, but a large percentage of measurement properties remained
unknown or unclear. It was therefore impossible to give a
judgement on several important quality criteria such as respon-
siveness, reproducibility, construct validity and interpretability.
The quality criteria used in this article might be considered
rather strict, since no questionnaire received satisfactory ratings
on all criteria. For example, an important aspect for several
psychometric properties was the definition of a minimal
important change. Since no minimal important change (MIC)
was defined for any of the questionnaires, it was therefore
impossible to receive a positive rating on agreement, respon-
siveness and interpretability. Defining a MIC is one of the most
important aspects of an evaluative questionnaire. Since half of
the questionnaires are aimed at the evaluation of ADL and
measuring change, one would expect more attention for this
aspect, especially in view of the use of these scales in clinical
trials and the relative weight put on IADL measures as outcome
variable by registration authorities. Another example of the
strictness of the criteria is the negative rating the B-ADL
received for internal consistency. The Cronbach alpha for this
questionnaire was too high according to the quality criteria. A
very high Cronbach alpha is indicative of redundancy of items,
but it does not necessarily mean that the internal consistency is
not good. Therefore, this negative rating is more indicative of
redundant items, and the questionnaire could possibly consist of
fewer items. We choose these quality criteria because they are
the most specific criteria currently available. These criteria
clearly pointed out flaws in the existent IADL questionnaires.
The methods used are often inadequate, and psychometric
information is lacking. These findings are in concordance with
previous reviews, in which serious limitations of ADL measure-
ment instruments were mentioned.54–56
Making recommendations about the use of IADL question-
naires is extremely difficult because of a lack of information.
When choosing a questionnaire, it is important to bear in mind
that a ‘‘good’’ score for many measurement properties is a start,
but in itself not enough. Which questionnaire is best depends on
the measurement aims. In general, one may say that respon-
siveness analyses are of particular importance for evaluative
questionnaires. For diagnostic questionnaires, a good reprodu-
cibility is important, in order to distinguish individuals from
each other. The applicability of the questionnaire, an aspect
that has not received attention in this review, can also be of
importance in choosing an appropriate questionnaire.
Even though this review indicated several serious limitations
in currently available IADL questionnaires, further investiga-
tions could result in better psychometric properties. Validation
is an ongoing process and can therefore improve over time when
new studies are conducted. Questionnaires with a positive
rating on content validity (ADL-PI, ADL-IS, Bristol ADL,
CSADL and DAD) provided an appropriate justification for
the items included in the questionnaire. The DAD also received
a positive rating on reliability and is therefore of particular
interest for further study. Our findings indicate that improve-
ments in psychometric properties of these questionnaires are
needed in order to justify their use in clinical practice and for
research purposes.
Table 3 Summary of the assessment of the measurement properties of all questionnaires measuring Instrumental Activities of Daily Living in patients
with dementia
Questionnaire
Content
validity
Internal
consistency
Criterion
validity
Construct
validity
Reproducibility
Responsiveness
Floor or ceiling
effect InterpretabilityAgreement Reliability
ADCS-ADL 2 NA NA NA NA NA NA NA NA
ADCS-ADL-Sev 2 NA NA ? NA NA ? NA NA
ADL-PI + NA NA ? NA ? ? NA ?
ADL-IS + NA NA ? NA NA NA NA ?
ADLQ NA NA NA ? NA ? ? NA ?
B-ADL 2* 2 NA ? NA ?* NA +* ?
Bristol ADL + NA NA +* NA ? ?* NA NA
Blessed DRS ? NA ? NA ? 2 NA NA ?
CSADL + ? NA ? NA ? NA 2 ?
DAD + ? NA ? NA + ? ? NA
IDDD NA ? NA NA NA ? NA NA ?
Lawton IADL 2{/NA{ NA{/+{ NA ? NA ? ? 2{/NA{ ?
Method or result was rated as: + positive; ? indeterminate; 2 negative.
*Data provided by personal communication. {Dementia patients. {Healthy older people.
NA, no data available.
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